Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs

Abstract Inherited retinal dystrophies are an important cause of blindness, for which currently there are no effective treatments. In order to study this heterogeneous group of diseases, adequate disease models are required in order to better understand pathology and to test potential therapies. Ind...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Conor M. Ramsden, Britta Nommiste, Amelia R. Lane, Amanda-Jayne F. Carr, Michael B. Powner, Matthew J. K. Smart, Li Li Chen, Manickam N. Muthiah, Andrew R. Webster, Anthony T. Moore, Michael E. Cheetham, Lyndon da Cruz, Peter J. Coffey
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2c6bb3edda1a42e7b46f27b3e51b9e86
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c6bb3edda1a42e7b46f27b3e51b9e86
record_format dspace
spelling oai:doaj.org-article:2c6bb3edda1a42e7b46f27b3e51b9e862021-12-02T11:41:12ZRescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs10.1038/s41598-017-00142-72045-2322https://doaj.org/article/2c6bb3edda1a42e7b46f27b3e51b9e862017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00142-7https://doaj.org/toc/2045-2322Abstract Inherited retinal dystrophies are an important cause of blindness, for which currently there are no effective treatments. In order to study this heterogeneous group of diseases, adequate disease models are required in order to better understand pathology and to test potential therapies. Induced pluripotent stem cells offer a new way to recapitulate patient specific diseases in vitro, providing an almost limitless amount of material to study. We used fibroblast-derived induced pluripotent stem cells to generate retinal pigment epithelium (RPE) from an individual suffering from retinitis pigmentosa associated with biallelic variants in MERTK. MERTK has an essential role in phagocytosis, one of the major functions of the RPE. The MERTK deficiency in this individual results from a nonsense variant and so the MERTK-RPE cells were subsequently treated with two translational readthrough inducing drugs (G418 & PTC124) to investigate potential restoration of expression of the affected gene and production of a full-length protein. The data show that PTC124 was able to reinstate phagocytosis of labeled photoreceptor outer segments at a reduced, but significant level. These findings represent a confirmation of the usefulness of iPSC derived disease specific models in investigating the pathogenesis and screening potential treatments for these rare blinding disorders.Conor M. RamsdenBritta NommisteAmelia R. LaneAmanda-Jayne F. CarrMichael B. PownerMatthew J. K. SmartLi Li ChenManickam N. MuthiahAndrew R. WebsterAnthony T. MooreMichael E. CheethamLyndon da CruzPeter J. CoffeyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Conor M. Ramsden
Britta Nommiste
Amelia R. Lane
Amanda-Jayne F. Carr
Michael B. Powner
Matthew J. K. Smart
Li Li Chen
Manickam N. Muthiah
Andrew R. Webster
Anthony T. Moore
Michael E. Cheetham
Lyndon da Cruz
Peter J. Coffey
Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs
description Abstract Inherited retinal dystrophies are an important cause of blindness, for which currently there are no effective treatments. In order to study this heterogeneous group of diseases, adequate disease models are required in order to better understand pathology and to test potential therapies. Induced pluripotent stem cells offer a new way to recapitulate patient specific diseases in vitro, providing an almost limitless amount of material to study. We used fibroblast-derived induced pluripotent stem cells to generate retinal pigment epithelium (RPE) from an individual suffering from retinitis pigmentosa associated with biallelic variants in MERTK. MERTK has an essential role in phagocytosis, one of the major functions of the RPE. The MERTK deficiency in this individual results from a nonsense variant and so the MERTK-RPE cells were subsequently treated with two translational readthrough inducing drugs (G418 & PTC124) to investigate potential restoration of expression of the affected gene and production of a full-length protein. The data show that PTC124 was able to reinstate phagocytosis of labeled photoreceptor outer segments at a reduced, but significant level. These findings represent a confirmation of the usefulness of iPSC derived disease specific models in investigating the pathogenesis and screening potential treatments for these rare blinding disorders.
format article
author Conor M. Ramsden
Britta Nommiste
Amelia R. Lane
Amanda-Jayne F. Carr
Michael B. Powner
Matthew J. K. Smart
Li Li Chen
Manickam N. Muthiah
Andrew R. Webster
Anthony T. Moore
Michael E. Cheetham
Lyndon da Cruz
Peter J. Coffey
author_facet Conor M. Ramsden
Britta Nommiste
Amelia R. Lane
Amanda-Jayne F. Carr
Michael B. Powner
Matthew J. K. Smart
Li Li Chen
Manickam N. Muthiah
Andrew R. Webster
Anthony T. Moore
Michael E. Cheetham
Lyndon da Cruz
Peter J. Coffey
author_sort Conor M. Ramsden
title Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs
title_short Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs
title_full Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs
title_fullStr Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs
title_full_unstemmed Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs
title_sort rescue of the mertk phagocytic defect in a human ipsc disease model using translational read-through inducing drugs
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/2c6bb3edda1a42e7b46f27b3e51b9e86
work_keys_str_mv AT conormramsden rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT brittanommiste rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT ameliarlane rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT amandajaynefcarr rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT michaelbpowner rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT matthewjksmart rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT lilichen rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT manickamnmuthiah rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT andrewrwebster rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT anthonytmoore rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT michaelecheetham rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT lyndondacruz rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
AT peterjcoffey rescueofthemertkphagocyticdefectinahumanipscdiseasemodelusingtranslationalreadthroughinducingdrugs
_version_ 1718395451048198144